ReviewJournal of experimental & clinical cancer research : CR2016

First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

Alessandra Fabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.